Skip to main content
Therapeutic Advances in Drug Safety logoLink to Therapeutic Advances in Drug Safety
. 2018 Jun 20;9(9):499–508. doi: 10.1177/2042098618781520

Effect of a voice recognition system on pediatric outpatient medication errors at a tertiary healthcare facility in Kenya

Angela N Migowa 1,, William M Macharia 2, Pauline Samia 3, John Tole 4, Alfred K Keter 5
PMCID: PMC6116775  PMID: 30181858

Abstract

Background:

Medication-related errors account for one out of every 131 outpatient deaths, and one out of 854 inpatient deaths. The risk is threefold greater in the pediatric population. In sub-Saharan Africa, research on medication-related errors has been obscured by other health priorities and poor recognition of harm attributable to such errors.

Our primary objective was to assess the effect of introduction of a voice recognition system (VRS) on the prevalence of medication errors. The secondary objective was to describe characteristics of observed medication errors and determine acceptability of VRS by clinical service providers.

Methods:

This was a before–after intervention study carried out in a Pediatric Accident and Emergency Department of a private not-for-profit tertiary referral hospital in Kenya.

Results:

A total of 1196 handwritten prescription records were examined in the pre-VRS phase and 501 in the VRS phase. In the pre-VRS phase, 74.3% of the prescriptions (889 of 1196) had identifiable errors compared with 65.7% in the VRS phase (329 of 501).

More than half (58%) of participating clinical service providers expressed preference for VRS prescriptions compared with handwritten prescriptions.

Conclusions:

VRS reduces medication prescription errors with the greatest effect noted in reduction of incorrect medication dosages. More studies are needed to explore whether more training, user experience and software enhancement would minimize medication errors further. VRS technology is acceptable to physicians and pharmacists at a tertiary care hospital in Kenya.

Keywords: medication errors, outpatient, pediatrics, safety, therapeutics

Introduction

The first Quality Chasm report of the Institute of Medicine’s (IOM), ‘To Err Is Human’ stated that medication-related errors accounted for 1 out of every 131 outpatient deaths and 1 out of 854 inpatient deaths.13 Provision of medication entails prescribing, verifying, dispensing, administering, monitoring and reporting.4 Studies estimate 68–75% of adverse drug events occur as a result of mistakes that occur during the prescription stage with illegible handwriting contributing significantly to medication errors.5,6 Errors may arise from any of the several stages of the prescription process, with the risk being threefold greater for pediatric medications.5 Dosage calculation in children is based on age, weight, body surface area or severity of the clinical condition. In addition, children have a narrow therapeutic window and a lower physiological threshold for buffering overdose errors compared with adults. Children also lack capacity to participate effectively in the medication process, thus placing them at greater risk for harm.2 The risk of medication errors is higher in outpatient settings where prescribers operating in a stressful work environment are less familiar with patients.

Interventions that have been used to reduce medication errors include enhancing knowledge on medication safety, development of reporting systems and implementation of safety systems in healthcare organizations at the delivery level.2,7,8 Other interventions include use of tutorials, computerized physician order forms and workbooks.911 Electronic prescription systems have immediate benefits of improving legibility and completeness while eliminating transcription errors.1214 In VRS, voice is used to input data into the computer through a microphone. A computer software then converts voice data into text and stores it in a database, facilitating retrieval for subsequent use. Though readily available, VRS use in the medication process is largely unexplored.15,16 Kang and colleagues used Dragon® voice application to prepare pathology reports and demonstrated an 81% decrease in average turnaround time and a 48% decrease in the number of errors identified before signing out the report.15 Proper training followed by practice in VRS use is considered crucial for the success of voice recognition in reducing errors.17

Medication errors among the pediatric population in sub-Saharan Africa remain largely understudied, hence there are limited data on effectiveness of various strategies to reduce medication errors in this region. The primary aim of this study was to determine if introduction of a voice recognition system (VRS) into the medication process would reduce the occurrence of prescription errors in a pediatric Accident and Emergency (A&E) department at a tertiary care hospital in Kenya. Our secondary objectives were to describe the pattern of medication errors, factors associated with their occurrence and to determine acceptability of VRS by prescribing doctors and dispensing pharmacists.

Methods

Study design and setting

We conducted a before–after observational study at the Aga Khan University Hospital (AKUH) pediatric A&E department and main pharmacy. AKUH is a private ‘not-for-profit’ tertiary care hospital in Nairobi that mainly caters to middle- and high-income earners.

Study procedures

Retrospective chart review was used to ascertain prescription and dispensing errors among senior house officers (SHOs), resident trainees and clinical instructors attending to clients at the pediatric A&E department. SHOs are recently licensed but non-specialized doctors; residents are pediatric trainees. Instructors are recently qualified pediatricians undergoing apprenticeship prior to licensing by the Kenya Medical Practitioners and Dentists Board. Doctors work in 6–12 hour shifts under supervision of the instructors but they all assess patients and prescribe independently.

A prescription error was defined as an omission or incorrect documentation of patient’s name, age, gender. Other errors included incorrect drug name, dose, route, frequency or duration as ascertained using the British National Formulary (BNF). A dispensing error was defined as a discrepancy between a correct prescription and the actual medication instructions that the dispensing pharmacist issued to the patient.

We conducted a retrospective chart review between May 2012 and April 2013 to ascertain prescription and dispensing errors among SHOs, resident trainees and clinical instructors attending to clients at the pediatric A&E department.

Intervention

In consultation with the AKUH department of information technology, a VRS was installed at the pediatric A&E and the main pharmacy prior to commencement of this study in May 2013. Installation entailed connecting a microphone to a computer based at the pediatric A&E department and linking it to the main hospital pharmacy through a central server. A medical dictionary consisting of common medical terms obtained from medication records obtained in the pre-VRS phase was set up and stored in the computer database. Doctors and pharmacists consenting to the use of VRS were then trained to enhance proficiency in its use. Voice profiles of participating doctors were also installed in order to enhance voice recognition.

The same team of doctors enrolled patients at the time of medical consultation with written informed consent from accompanying guardians. Patients then physically presented the VRS prescription at the main pharmacy to obtain their medications. Dispensing pharmacists verified biodata and medication particulars of patients from a label affixed to the medication package before dispensing with instructions on usage. We then analyzed medication particulars on VRS prescriptions and their corresponding dispensing records to determine the proportion of prescription errors and dispensing errors. At the end of the study, the doctors and pharmacists were requested to indicate whether they found the electronic VRS to be acceptable for medical prescription.

Data abstraction

Information extracted from prescription and dispensing records in the period before and after introduction of VRS included drug name, dose, route, frequency and duration of treatment. The corresponding biodata of patients, diagnosis, professional category of prescriber (SHO, resident or instructor) and time of day the prescription was made were retrieved from medical records and documented in a standard study tool.

Ethical considerations

Ethical consent procedures were reviewed and approved by the AKUH ethical review committee, Ref 2012/26 (V3). Written informed consent was obtained from parents of all participating study children. Consent was also obtained from prescribing doctors and pharmacists. Investigators gave non-disclosure guarantee on identities of participants unless with prior approval.

Errors identified at the prescription stage were noted and immediately rectified in consultation with the attending physician. Where errors were identified at the dispensing stage, the principal investigator recorded the same and informed the pharmacist to amend the dispensing label prior to dispensing the medication.

Sample size

In the absence of local information, sample size estimation for the number of prescriptions needed for analysis was based on a prior study by Kang and colleagues that reported 14% prevalence of medication errors and an error reduction of 48% following introduction of VRS.16 A minimum number of 496 in each arm was needed to provide 90% power with a 95% confidence interval.

Data management and analysis

Information was then entered into excel tables secured in a password-protected computer. Each entry was then reassessed to ensure all variables were entered correctly. In the case of missing information, medical, prescription and dispensing records were reanalyzed to capture the missing information.

Data was analyzed using STATA version 13 (StataCorp. 2013. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP. It is manufactured by StataCorp in Texas USA). Demographic characteristics for both phases of the study were summarized as frequencies and proportions. The proportion of prescription or dispensing errors was compared between handwritten prescriptions and VRS-generated prescriptions using chi-square tests. Two sample tests for proportions were used to assess for significant differences in prescription errors for periods before and after intervention with stratification by work shift and doctor’s designation. The Mantel-Haenszel method was used to estimate odds ratios (ORs) of prescription errors between the pre-VRS and VRS phase. Acceptability of VRS by healthcare providers was estimated using simple proportions.

Results

A total of 1196 handwritten prescription records were examined in the pre-VRS phase and 501 in the VRS phase. Table 1 illustrates the biodemographic characteristics of study participants.

Table 1.

Biodemographic characteristics of study participants.

Pre-VRS
During VRS
Total
n % n % n %
Sex of child
 Male 696 58.2 226 45.1 922 54.3
 Female 459 38.4 275 54.9 734 43.3
 Missing 41 3.4 0 0 41 2.4
Shift worked
 Morning 377 31.5 99 19.8 476 28
 Afternoon 391 32.7 246 49.1 637 37.5
 Evening 394 32.9 156 31.1 550 32.4
 Missing 34 2.8 0 0 34 2
Designation
 Instructor 550 46 229 45.7 779 45.9
 Consultant 13 1.1 0 0 13 0.8
 Resident 167 14 126 25.2 293 17.3
 SHO 393 32.9 146 29.1 539 31.8
 Intern 44 3.7 0 0 44 2.6
 Unknown/missing 29 2.4 0 0 29 1.7
Age categories (years)
 0–1 281 23.5 79 15.8 360 21.2
 1–5 518 43.3 261 52.1 779 45.9
 5–10 269 22.5 133 26.6 402 23.7
 10–15 95 7.9 28 5.6 123 7.2
 Missing 33 2.8 0 0 33 1.9
Total 1196 100 501 100 1697 100

SHO, senior house officer; VRS, voice recognition system.

NOTE: The bold figures demonstrates the totals i.e if one is to add all the entries Sex of child it should add up to 1196.

In the pre-VRS phase, 74.3% of the prescriptions (889 of 1196) had identifiable errors compared with 65.7% in the VRS phase (329 of 501).

Among prescription errors analyzed, the greatest impact of introduction of VRS was in reduction of incorrect medication dose. Incorrect medication doses were reduced by 13.4% with use of VRS (p < 0.0001). In the pre-VRS phase, 21.4% (256/1196) of the prescriptions had incorrect doses compared with only 8% (40/501) in the VRS phase (p < 0.0001). Unfortunately, as shown in Table 2, use of VRS was associated with an increase in errors related to documentation of drug name, drug frequency and duration of treatment.

Table 2.

Prescription errors before and after introduction of voice recognition system.

Pre-VRS
During VRS
Total
n % n % n % p-value
Drug name
 Correct 1163 97.2 468 93.4 1631 96.1 0.000
 Incorrect 33 2.8 33 6.6 66 3.9
Drug dose
 Correct 739 61.8 377 75.2 1116 65.8 0.000
 Incorrect 256 21.4 40 8 296 17.4
 Omitted 201 16.8 84 16.8 285 16.8
Drug route
 Correct 699 58.4 316 63.1 1015 59.8 0.206
 Incorrect 10 0.8 4 0.8 14 0.8
 Omitted 487 40.7 181 36.1 668 39.4
Drug frequency
 Correct 886 74.1 361 72.1 1247 73.5 0.000
 Incorrect 253 21.2 84 16.8 337 19.9
 Omitted 57 4.8 56 11.2 113 6.7
Drug duration
 Correct 975 81.5 409 81.6 1384 81.6 0.000
 Incorrect 83 6.9 11 2.2 94 5.5
 Omitted 138 11.5 81 16.2 219 12.9
Omission in prescription1
 No 505 42.2 237 47.3 742 43.7 0.054
 Yes 691 57.8 264 52.7 955 56.3
Incorrect prescription2
 No 684 57.2 346 69.1 1030 60.7 0.000
 Yes 512 42.8 155 30.9 667 39.3
Any prescription errors
 Correct 307 25.7 172 34.3 479 28.2 0.000
 Incorrect 889 74.3 329 65.7 1218 71.8
1

Omission of indicating either drug name, dose, route frequency or duration.

2

Incorrect prescription regarding either drug name, dose, route frequency or duration, excluding omissions.

VRS, voice recognition system.

There were no significant differences noted in dispensing errors with use of VRS. There were 92.7% errors noted in the pre-VRS phase (1030 of 1111) compared with 93.3% in the VRS phase (332 of 356). The use of VRS was associated with an increase in omission of duration of medication prescription (p = 0.006). The effect of introduction of VRS on dispensing errors is shown in Table 3.

Table 3.

Dispensing errors before and after introduction of voice recognition system.

Pre-VRS
During VRS
Total
n % n % n % p-value
Drug name
 Correct 1074 96.7 334 93.8 1408 96 0.017
 Incorrect 37 3.3 22 6.2 59 4
Drug dose
 Correct 765 68.9 264 74.2 1029 70.1 0.006
 Incorrect 208 18.7 41 11.5 249 17
 Omitted 138 12.4 51 14.3 189 12.9
Drug route
 Correct 516 46.4 156 43.8 672 45.8 0.688
 Incorrect 9 0.8 3 0.8 12 0.8
 Omitted 586 52.7 197 55.3 783 53.4
Drug frequency
 Correct 803 72.3 242 68 1045 71.2 0.246
 Incorrect 196 17.6 69 19.4 265 18.1
 Omitted 112 10.1 45 12.6 157 10.7
Drug duration
 Correct 232 20.9 56 15.7 288 19.6 0.006
 Incorrect 27 2.4 2 0.6 29 2
 Omitted 852 76.7 298 83.7 1150 78.4
Dispensing omission1
 No 115 10.4 27 7.6 142 9.7 0.124
 Yes 996 89.6 329 92.4 1325 90.3
Incorrect dispensing2
 No 708 63.7 235 66 943 64.3 0.434
 Yes 403 36.3 121 34 524 35.7
Dispensing errors
 Correct 81 7.3 24 6.7 105 7.2 0.726
 Incorrect 1030 92.7 332 93.3 1362 92.8
Total (n) 1111 356 1467
1

Omission of indicating either drug name, dose, route frequency or duration when dispensing.

2

Incorrect dispensing regarding either drug name, dose, route frequency or duration, excluding omissions.

VRS, voice recognition system.

Introduction of VRS was associated with a reduction in the proportion of errors noted in the afternoon and evening shifts by 8.6% (p = 0.023) and 13.3 % (p = 0.002), respectively. Similarly, residents and SHOs demonstrated a reduction in prescription errors by 19.9% (p < 0.001) and 14% (p = 0.001), respectively, as shown in Table 4.Use of VRS was associated with a reduction in proportion of prescription errors by 33% and 46% in the afternoon and evening shift, respectively. Among the various cadres of healthcare workers, the greatest risk reduction in errors with the use of VRS was noted among residents with a 61% reduction in the odds of committing prescription errors. Table 5 shows the effect of shift and designation on the occurrence of errors.

Table 4.

Proportion of prescription errors by shift and designation of doctors.

Pre-VRS
During VRS
Total
p-value
n % n % n %
Shift
 Morning 284 75.3 76 76.8 360 75.6 0.767
 Afternoon 286 73.2 159 64.6 445 69.9 0.023
 Evening 290 73.6 94 60.3 384 69.8 0.002
Designation
 Instructor 402 73.1 166 72.5 568 72.9 0.863
 Resident 130 77.8 73 57.9 203 69.3 0.000
 SHO 297 75.6 90 61.6 387 71.8 0.001

SHO, senior house officer; VRS, voice recognition system.

Table 5.

Overall risk of prescription errors by shift and designation of doctors.

Odds ratio 95% CI
Crude 0.66 0.53 0.83
Shift worked
 Morning 1.08 0.64 1.82
 Afternoon 0.67 0.48 0.95
 Evening 0.54 0.37 0.80
M-H combined 0.69 0.55 0.87
Designation
 Instructor 0.97 0.69 1.37
 Resident 0.39 0.24 0.65
 SHO 0.52 0.35 0.78
M-H combined 0.65 0.52 0.82

CI, confidence interval; M-H, Mantel-Haenszel; SHO, senior house officer.

A total of 58% of the healthcare providers interviewed (7/12) expressed desire for future use of VRS in the medication process. Some of the advantages noted by healthcare providers in using VRS were that it saved time during the prescription process and reduced errors associated with illegibility. Pharmacists observed that diction was a challenge in the utilization of VRS as they often had to log on to a separate online system to access VRS-generated prescriptions, which was perceived to increase workload.

Five out of twelve of the healthcare providers proposed incorporation of VRS into the hospital online information system, while one recommended expansion of the medical dictionary within the VRS to allow for comprehensive identification of medical terms. Other proposals made were to incorporate a prescription template and an online drug list within the software to automate dosages, route and frequency.

Discussion

This study was conducted in a pediatric A&E department of a private, not-for-profit, tertiary healthcare facility to primarily establish if introduction of a VRS would reduce medication errors. We demonstrated that overall, 74.3% (889 of 1196) of prescriptions in the pre-VRS phase had errors compared with 65.7% (329 of 501) in the VRS phase. These are unacceptably high error rates which may be attributed to how medication error was defined. Our study did not, for instance, include missing or wrong patient weight and errors in prescription dates in the list of errors. Kang and colleagues, using a similar VRS system on pathology reporting observed 48% reduction in errors.15 Further studies are required to ascertain how best to incorporate VRS within already existing health systems to maximize on its benefits.

In this study, the greatest impact of VRS introduction was in reduction of incorrect drug dosage. This advantage was, however, countered by an increase in wrong documentation of drug name, and failure to indicate frequency and duration of treatment. Our study, however, was not powered for a detailed subanalysis of the many variables in this study. These serious prescription omissions and commissions may be attributed to inadequacy in staff training and experience in using the new system. Antiles and colleagues indeed emphasized how crucial training and experience are for the successful use of the technology.17 Errors may also have been minimized if the VRS had been programmed to make it mandatory for all critical information to be entered before the user could proceed with the prescription process. Automation of dosages computed from weight or age entries could reduce errors even further. Fortunately, we did not find any incident of administering medications to the wrong patient during the study period.

The greatest impact of reduction in prescription errors was noted among residents and SHOs. This may be accounted for by the fact that junior doctors are yet to establish their prescription habits and patterns. Consequently, they readily take up new practices to improve prescription habits. Implementation of VRS reduced the prescription errors occurring in the afternoon and evening shifts. We postulate that this was due to the fact that most of these shifts were done by residents and SHOs.

The majority of our study respondents preferred VRS prescriptions compared with handwritten prescriptions. They were of the view that VRS reduced prescription illegibility, was user friendly and saved time. Diction was, however, of concern to dispensing pharmacists and will require further studies to provide software solutions.

In hospitals without online prescribing systems, patient information is typically dispersed in a collection of paper records that are poorly organized, illegible, and not easy to retrieve.7 Thus, information technology holds untapped potential for improving efficiency in healthcare delivery systems with positive impact on service quality and client satisfaction. Since VRS software can be downloaded from the internet at no cost, incorporation of VRS into hospital systems should be considered when facilities undertake digitalization of patient data. Equipment procurement, setup and maintenance may still be cost effective, given the high cost of manual record keeping and risk of serious harm to patients. The effect of more intensive training and close prescription monitoring with feedback warrants further study in efforts to lower error rates associated with use of the electronic system. Our study was not designed to assess cost effectiveness of VRS but we recommend that future studies ascertain the cost effectiveness of the free VRS software in the medication process.

Before–after trials have the inherent drawback of inability to control for changes that may take place over time and which would be beyond the control of investigators. A randomized trial would be preferable in assessment of effectiveness of VRS. However, in a relatively small A&E unit, with 11 full-time staff doing different shifts, it would present challenges, as blinding would not be possible. Implementation of VRS poses various logistical challenges too. During the study, it was not possible to integrate the existing pharmacy online system with the VRS due to software incompatibility. Despite creating a medical dictionary within the VRS, repeated trials at dictation and editing of medical terms were required during its use. Consequently, the greatest disadvantage cited by dispensing pharmacists during this study was diction that may have contributed to increased incidence in incorrect drug name entry in the VRS phase. Local customization of software that takes diction into account requires further exploration.

While acknowledging VRS prescription performed well below our expectation, our findings demonstrate the potential of using modern information technology to improve patient safety, provided areas of concern that we have highlighted are systematically addressed. As the Chair of the Committee on Quality of Health Care in America states, limited awareness on the magnitude of medication errors and extent to which healthcare professionals have fallen short of making optimal use of technology to improve healthcare safety explains in part the slow uptake of technology in the medication process.7 We hope that similar larger studies will lead to improvement in quality of medical prescription electronic software.

Conclusion

Implementation of VRS in the medication process has the potential to reduce medication errors, with the greatest impact noted particularly in reduction of incorrect dosages. Further research is recommended to determine if more user training, experience, close monitoring of prescriptions and software improvement will minimize drawbacks associated with VRS. Since VRS can be downloaded from the internet at no cost and appears to be acceptable to prescribing physicians and dispensing pharmacists, further studies should be undertaken to improve performance and assess cost effectiveness.

Acknowledgments

We thank the families, doctors and pharmacists for agreeing to participate in this study. We also extend our appreciation to Dr T Egondi and Ms N Khaemba for all the statistical support. We are grateful to Aga Khan University Hospital Information Technology department and the Research Support Unit of Aga Khan University Hospital for supporting this work.

Footnotes

Funding: This study was undertaken with financial support from Aga Khan University Research Council under Research Ethics committee approval ref: 2012/26(v3).

Conflict of interest statement: The authors declare that there is no conflict of interest.

Contributor Information

Angela N. Migowa, Department of Pediatrics and Child Health, Aga Khan University, 3rd Parklands Avenue, PO Box 30270, Nairobi County 00100, Kenya.

William M. Macharia, Department of Pediatrics and Child Health, Aga Khan University, Kenya

Pauline Samia, Department of Pediatrics and Child Health, Aga Khan University, Kenya.

John Tole, Department of Pediatrics and Child Health, Aga Khan University, Kenya.

Alfred K. Keter, Department of Medicine, Moi University, Kenya

References

  • 1. Otero P Leyton A Mariani G et al.;. Patient Safety Committee. Medication errors in pediatric inpatients: prevalence and results of a prevention program. Pediatrics 2008; 122: 737–743. [DOI] [PubMed] [Google Scholar]
  • 2. Kohn LT, Corrigan JM, Donaldson MS. To err is human: building a safer health system. Washington, DC: Institute of Medicine National Academy Press, 2000. [PubMed] [Google Scholar]
  • 3. Campino A, Lopez-Herrera M, Lopez-de-Heredia I, et al. Medication errors in a neonatal intensive care unit. Influence of observation on the error rate. Acta Paediatr 2008; 97: 1589–1594. [DOI] [PubMed] [Google Scholar]
  • 4. Kadmon G, Bron-Harlev E, Nahum E, et al. Computerized order entry with limited decision support to prevent prescription errors in a PICU. Pediatrics 2009; 124: 935–940. [DOI] [PubMed] [Google Scholar]
  • 5. Lee B, Lehmann C, Jackson E, et al. Assessing controlled substance prescribing errors in a pediatric teaching hospital: an analysis of the safety of analgesic prescription practice in the transition from the hospital to home. J Pain 2009; 10: 160–166. [DOI] [PubMed] [Google Scholar]
  • 6. Rathish D, Bahini S, Sivakumar T, et al. Drug utilization, prescription errors and potential drug-drug interactions: an experience in rural Sri Lanka. BMC Pharmacol Toxicol 2016; 17: 27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Hakkarainen KM, Gyllensten H, Jönsso AK, et al. Prevalence, nature and potential preventability of adverse drug events – a population-based medical record study of 4970 adults. Br J Clin Pharmacol 2014; 78(1): 170–183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Richardson W, Berwick D, Bisgard J. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press, 2001. [PubMed] [Google Scholar]
  • 9. Beck S, Bratnikov Y, Brown L. Improving medication safety in community pharmacy. Assessing risk and opportunities for change. Washington, DC: Institute for Safe Medication Practices, 2009. [Google Scholar]
  • 10. Hughes R, Blegen M. Medication administration safety. Washington, DC: Institute of Medicine, 2007. [Google Scholar]
  • 11. Hitti E, Tamim H, Bakhti R, et al. Impact of internally developed electronic prescription on prescribing errors at discharge from the emergency department. West J Emerg Med Aug 2017; 18: 943–949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Samadbeik M, Ahmadi M, Sadoughi F, et al. A copmarative review of electronic prescription systems: lessons learned from developed countries. J Res Pharm Pract 2017; 6: 3–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Joshi A, Buch J, Kothari N, et al. Evaluation of hand written and computerized out-patient prescriptions in urban part of central Gujarat. J Clin Diagn Res 2016; 10: FC01–FC05. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Stultz JS, Nahata MC. Preventability of voluntarily reported or trigger tool-identified medication errors in a pediatric institution by information technology: a retrospective cohort study. Drug Saf 2015; 38: 661–670. [DOI] [PubMed] [Google Scholar]
  • 15. Ahmed IA, Eman AR, Rwaa KF, et al. Assessment of legibility and completeness of handwritten and electronic prescriptions. Saudi Pharm J 2014; 22: 522–527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Kang PH, Sirintrapun J, Nestler RJ, et al. Experience with voice recognition in surgical pathology at a large academic multi-institutional center. Am J Clin Pathol 2010; 133: 156–159. [DOI] [PubMed] [Google Scholar]
  • 17. Cohen PR, Oviatt SL. The role of voice input for human-machine communication. Proc Natl Acad Sci U S A 1995; 92: 9921–9927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Antiles S, Couris J, Schweitzer A, et al. Project planning, training, measurement and sustainment: the successful implementation of voice recognition. Radiol Manage 2000; 22: 18–31. [PubMed] [Google Scholar]

Articles from Therapeutic Advances in Drug Safety are provided here courtesy of SAGE Publications

RESOURCES